Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonshik Han

Showing results (301-310 of 384) with videos related to

Pageof 39
Sort By:
Plos One|April 14, 2015
Prediction of breast cancer survival using clinical and genetic markers by tumor subtypesNan Song, Ji-Yeob Choi, Hyuna Sung, et al.
Breast Cancer Research : BCR|March 4, 2011
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosisBhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, et al.
Cancer Science|November 21, 2014
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapyHee-Jun Kim, Seock-Ah Im, Bhumsuk Keam, et al.
Breast Cancer Research and Treatment|January 24, 2019
Prognostic effects of abnormal DNA damage response protein expression in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Journal of Breast Cancer|April 18, 2013
Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsJune Koo Lee, Seock-Ah Im, Daewon Lee, et al.
Cancer Research and Treatment|February 7, 2017
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer SurgerySoo Kyung Ahn, Min Kyoon Kim, Jongjin Kim, et al.
Oncology|August 22, 2012
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapyJi-Won Kim, Jee Hyun Kim, Seock-Ah Im, et al.
Molecular & Cellular Proteomics : MCP|July 30, 2011
A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancersSeok-Won Hyung, Min Young Lee, Jong-Han Yu, et al.
Breast Cancer (Tokyo, Japan)|February 8, 2012
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapyBhumsuk Keam, Seock-Ah Im, Youngil Koh, et al.
BMC Cancer|February 21, 2022
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trialJi Gwang Jung, Se Hyun Ahn, Seeyoun Lee, et al.
Pageof 39

Showing results (301-310 of 384) with videos related to

Sort By:
Pageof 39
Plos One|April 14, 2015
Prediction of breast cancer survival using clinical and genetic markers by tumor subtypesNan Song, Ji-Yeob Choi, Hyuna Sung, et al.
Breast Cancer Research : BCR|March 4, 2011
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosisBhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, et al.
Cancer Science|November 21, 2014
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapyHee-Jun Kim, Seock-Ah Im, Bhumsuk Keam, et al.
Breast Cancer Research and Treatment|January 24, 2019
Prognostic effects of abnormal DNA damage response protein expression in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Journal of Breast Cancer|April 18, 2013
Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsJune Koo Lee, Seock-Ah Im, Daewon Lee, et al.
Cancer Research and Treatment|February 7, 2017
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer SurgerySoo Kyung Ahn, Min Kyoon Kim, Jongjin Kim, et al.
Oncology|August 22, 2012
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapyJi-Won Kim, Jee Hyun Kim, Seock-Ah Im, et al.
Molecular & Cellular Proteomics : MCP|July 30, 2011
A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancersSeok-Won Hyung, Min Young Lee, Jong-Han Yu, et al.
Breast Cancer (Tokyo, Japan)|February 8, 2012
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapyBhumsuk Keam, Seock-Ah Im, Youngil Koh, et al.
BMC Cancer|February 21, 2022
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trialJi Gwang Jung, Se Hyun Ahn, Seeyoun Lee, et al.
Pageof 39